Yada Kanjanapan
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 27, 2023
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting.Yada Kanjanapan, Geetha Guduguntla, Ashwati Krishnan Varikara
|Jun 22, 2021
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.Yada Kanjanapan, Prunella Blinman, Craig Underhill
|Nov 07, 2020
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy.Yada Kanjanapan, Desmond Yip
|Oct 09, 2020
Considerations for cancer immunotherapy during the COVID-19 pandemic.Yada Kanjanapan, Desmond Yip
|Aug 12, 2020
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.Yada Kanjanapan, Sheau Wen Lok, Peter Gibbs
|May 23, 2020
Acute ischaemic stroke following cisplatin-based chemotherapy for testicular cancer.Yada Kanjanapan, Daniel Gilbourd, Ganesalingam Pranavan
Pageof 2
